CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-05 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Restricted Stock Unit | −8,333 | 0 | ||
| 2018-03-05 | Sardesai Niranjan Chief Operating Officer | Grant or award · Common Stock Option | +126,500 | 126,500 | ||
| 2018-03-05 | Sardesai Niranjan Chief Operating Officer | Grant or award · Restricted Stock Unit | +82,700 | 82,700 | ||
| 2018-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +13,333 | 2,178,533 | ||
| 2018-03-05 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −3,711 | $4.29 | $16K | 2,174,822 |
| 2018-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −13,333 | 0 | ||
| 2018-03-05 | Kim Jong Joseph Chief Executive Officer | Grant or award · Common Stock Option | +138,250 | 138,250 | ||
| 2018-03-05 | Kim Jong Joseph Chief Executive Officer | Grant or award · Restricted Stock Unit | +360,300 | 360,300 | ||
| 2017-12-05 | YARNO WENDY L Director | Grant or award · Common Stock Option | +20,000 | $4.38 | $88K | 20,000 |
| 2017-12-05 | YARNO WENDY L Director | Grant or award · Restricted Stock Unit | +12,270 | 12,270 | ||
| 2017-07-28 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +61,325 | $5.08 | $312K | 2,165,200 |
| 2017-07-28 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Common Stock Option | −61,325 | 0 | ||
| 2017-05-25 | Weiner David B. Director | Sale | −8,000 | $8.00 | $64K | 740,956 |
| 2017-05-13 | BENITO SIMON X Director | Exercise or conversion | +10,000 | 27,798 | ||
| 2017-05-13 | BENITO SIMON X Director | Exercise or conversion · Restricted Stock Unit | −10,000 | 0 | ||
| 2017-05-13 | MAHMOUD ADEL Director | Exercise or conversion | +10,000 | 15,000 | ||
| 2017-05-13 | MAHMOUD ADEL Director | Exercise or conversion · Restricted Stock Unit | −10,000 | 0 | ||
| 2017-05-13 | Cabrera Angel Director | Exercise or conversion | +10,000 | 51,750 | ||
| 2017-05-13 | Cabrera Angel Director | Exercise or conversion · Restricted Stock Unit | −10,000 | 0 | ||
| 2017-05-13 | DHILLON AVTAR S Director | Exercise or conversion | +10,000 | 73,333 |
Page 43 of 49 · 961 trades